Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anika Therapeutics (NQ: ANIK )

23.00 +0.44 (+1.95%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 99,307
Open 22.97
Bid (Size) 15.80 (1)
Ask (Size) 37.16 (1)
Prev. Close 22.56
Today's Range 22.78 - 23.49
52wk Range 19.95 - 45.81
Shares Outstanding 14,599,937
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Anika Therapeutics: Q2 Earnings Insights
Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine
From Anika Therapeutics Inc.
Via Globe NewsWire

Performance

YTD
-37.05%
-37.05%
1 Month
+2.50%
+2.50%
3 Month
+8.24%
+8.24%
6 Month
-26.00%
-26.00%
1 Year
-43.45%
-43.45%

More News

Read More
Sidoti's Summer Small Cap Virtual Conference
From Sidoti & Company, LLC
Via AccessWire
New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Anika Therapeutics: Q4 Earnings Insights
Via Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Via Benzinga
Earnings Scheduled For March 8, 2022
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Via Benzinga
Anika Therapeutics, inc (ANIK) Q3 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Return on Capital Employed Insights for Anika Therapeutics
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021
Via Benzinga
Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Via Benzinga
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021
Via Benzinga
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements
Via Benzinga
Exposures Product Safety
Anika Therapeutics Inc (ANIK) Q1 2021 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.